Stimulation of bile acid 6α-hydroxylation by rifampin

Journal of Hepatology

Volumn 24, Issue 6, 1996, Pages 713-718

  Wietholtz, Hubertus ^a,c   Marschall, Hanns Ulrich ^a   Jan, Sjövall ^b   Matern, Siegfried ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b KAROLINSKA INSTITUTE   (Sweden)

^c KLINIKUM DARMSTADT   (Germany)

Author keywords

Bile acids; Cholestasis; Gas chromatography mass spectrometry; Glucuronidation; Hydroxylation; Pruritus; Rifampin; Sulphation; Urine

Indexed keywords

BILE ACID; RIFAMPICIN;

ADULT; ARTICLE; CHOLESTASIS; FEMALE; GLUCURONIDATION; HUMAN; HYDROXYLATION; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; URINALYSIS;

EID: 0030159011     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(96)80268-6     Document Type: Article

References (43)

1. Garden JM, Ostrow JD, Roenigk HH. Pruritus in hepatic cholestasis. Pathogenesis and therapy. Arch Dermatol. 121:1985;1415-1420.
2. Schoenfield LJ, Sjövall J, Perman E. Bile acids on the skin of patients with pruritic hepatobiliary disease. Nature. 213:1967;93-94.
3. Stiehl A. Bile acids and bile acid sulfates in the skin of patients with cholestasis and pruritus. Z Gastroenterol. 12:1974;121-124.
4. Ghent CN, Bloomer JR, Klatskin G. Elevations in skin tissue levels of bile acids in human cholestasis: relation to serum levels and to pruritus. Gastroenterology. 73:1978;1125-1130.
5. Freedman MR, Holzbach RT, Ferguson DR. Pruritus in cholestasis: no direct causative role for bile acid retention. Am J Med. 70:1981;1011-1016.
6. Ghent CN. Pruritus of cholestasis is related to effects of bile salts on the liver, not the skin. Am J Gastroenterol. 82:1987;117-118.
7. Galeazzi R, Lorenzini I, Orlandi F. Rifampicin-induced elevation of serum bile acids in man. Dig Dis Sci. 25:1980;108-112.
8. Ghent CN, Carruthers SG. Treatment of pruritus in primary biliary cirrhosis. Results of a double-blind, crossover, randomized trial. Gastroenterology. 94:1988;488-493.
9. Cynamon HA, Andres JM, Iafrate RP. Rifampin relieves pruritus in children with cholestatic liver disease. Gastroenterology. 98:1990;1013-1016.
10. Acocella G. Clinical pharmacokinetics of rifampicin. Clin Pharmacokinet. 3:1978;108-127.
11. Kenny MT, States B. Metabolism and pharmacokinetics of the antibiotic rifampin. Drug Metabol Rev. 12:1981;159-218.
12. Wietholz H, Marschall HU, Reuschenbach R, Matern H, Matern S. Urinary excretion of bile acid glucosides and glucuronides in extrahepatic cholestasis. Hepatology. 13:1991;656-662.
13. Marschall HU, Matern H, Wietholtz H, Egestad B, Matern S, Sjövall J. Bile acid N-acetylglucosaminidation. In vivo and in vitro evidence for a selective conjugation reaction of 7β-hydroxylated bile acids in man. J Clin Invest. 89:1992;1981-1987.
14. Marschall HU, Matern H, Egestad B, Matern S, Sjövall J. 6α-Glucuronidation of hyodeoxycholic acid by human liver, kidney and small bowel microsomes. Biochim Biophys Acta. 921:1987;392-397.
15. Park BK. A direct radioimmunoassay for 6β-Hydroxycortisol in human urine. J Steroid Biochem. 9:1978;963-966.
16. Marshall HU, Griffiths WJ, Götze U, Zhang J, Wietholtz H, Busch N, Sjövall J, Matern S. The major metabolites of ursodeoxycholic acid in human urine are conjugated with N-acetylglucosamine. Hepatology. 20:1994;845-853.
17. Park BK. Assessment of urinary 6β-hydroxycortisol as an in vivo index of mixed function oxygenase activity. Br J Clin Pharmacol. 19:1981;97-102.
18. Ohnhaus EE, Breckenridge AM, Park BK. Urinary excretion of 6β-hydroxycortisol and the time course measurement of enzyme induction in man. Eur J Clin Pharmacol. 36:1989;39-46.
19. Dutton GJ. Glucuronidation of Drugs and Other Compounds. 1980;CRC PRess Inc. Boca Raton FL.
20. Back P, Spaczynski K, Gerok W. Bile-salt glucuronides in urine. Hoppe-Seyler's Z Physiol Chem. 355:1974;749-752.
21. Almé B, Norden A, Sjövall J. Glucuronides of unconjugated 6-hydroxylated bile acids in urine of a patient with malabsorption. Clin Chim Acta. 86:1978;251-259.
22. Almé B, Sjövall J. Analysis of bile acid glucuronides in urine: identification of 3α,6α,12α-trihydroxy-5β-β-cholanoic acid. J Steroid Biochem. 13:1980;907-916.
23. Saquet E, Parquet M, Riottot M, Raizman A, Jarrige P, Huguet C, Infante R. Intestinal absorption, excretion, and biotransformation of hyodeoxycholic acid in man. J Lipid Res. 24:1983;604-13.
24. Radominska-Pyrek A, Zimniak P, Irshaid YM, Lester R, Tephly TR, Pyrek JSt. Glucuronidation of 6α-hydroxy bile acids by human liver microsomes. J Clin Invest. 80:1987;234-241.
25. Parquet M, Pessah M, Saquet E, Salvat C, Raizman A. Effective glucuronidation of 6α-hydroxylated bile acids by human hepatic and renal microsomes. Eur J Biochem. 171:1988;329-334.
26. Matern H, Matern S, Schelzig CH, Gerok W. Bile acid UDP-glucuronyltransferase from human liver: properties and studies on aglycone substrate specificity. FEBS Lett. 118:1980;251-224.
27. Matern S, Matern H, Farthmann EH, Gerok W. Hepatic and extrahepatic glucuronidation of bile acids in man: characterization of bile acid uridine 5′-diphosphate-glucuronosyltransferase in hepatic, renal, and intestinal microsomes. J Clin Invest. 74:1984;402-410.
28. Back P. Urinary bile acids. Setchell KDR, Kritchevsky D, Nair PP. The Bile Acids, Methods and Applications. 4:1988;405-440 Plenum Press, New York.
29. Bolt HM, Bolt M, Kappus H. Interaction of rifampicin treatment with pharmacokinetics and metabolism of ethinylestradiol in man. Acta Endocrinol. 85:1977;189-197.
30. Nakashima T, Sano A, Seto Y, Nakajima T, Shima T, Sakamoto Y, Okuno T, Kashima K, Hasegawa T. Unusual trihydroxy bile acids in the urine of patients treated with chenodeoxycholate, ursodeoxycholate or rifampicin and those with cirrhosis. Hepatology. 11:1990;255-260.
31. Back P. Phenobarbital-induced alterations of bile acid metabolism in cases of intrahepatic cholestasis. Klin Wochenschr. 60:1982;541-549.
32. Stiehl A, Becker M, Czygan P, Fröhling W, Kommerell B, Rotthauwe HW, Senn M. Bile acids and their sulphated and glucuronidated derivatives in bile, plasma and urine of children with intrahepatic cholestasis: effects of phenobarbital treatment. Eur J Clin Invest. 10:1980;307-316.
33. Bremmelgaard A, Sjövall J. Bile acid profiles in urine of patients with liver diseases. Eur J Clin Invest. 9:1979;341-348.
34. Bremmelgaard A, Sjövall J. Hydroxylation of cholic, chenodeoxycholic and deoxycholic acids in patients with intrahepatic cholestasis. J Lipid Res. 21:1980;1072-1081.
35. Derks HJGM, Drayer NM. The identification and quantification of three new 6α-hydroxylated corticosteroids in human neonatal urine. Steroids. 31:1978;289-305.
36. Shackleton CHL, Honour JW, Taylor NF. Metabolism of fetal and neonatal steroids. J Steroid Biochem. 11:1979;523-529.
37. Setchell KDR, Street MJ, Sjövall J. Fecal bile acids. Setchell KDR, Kritchevsky D, Nair PP. The Bile Acids, Methods and Applications. 4:1988;441-570 Plenum Press, New York.
38. Hofmann AF. Bile acids. Arias IM, Jakoby WB, Popper H, Schachter D, Shafritz DA. The Liver: Biology and Pathobiology. 1988;553-572 Raven Press, New York.
39. Varadi DP. Pruritus induced by crude bile and purified bile acids. Arch Dermatol. 109:1974;678-681.
40. Kirby J, Heaton KW, Burton JL. Pruritic effect of bile salts. Br Med J. 4:1974;693-695.
41. Hoensch HP, Balzer K, Dylewicz P, Kirch W, Goebell H, Ohnhaus EE. Effect of rifampicin treatment on hepatic drug metabolism and serum bile acids in patients with primary biliary cirrhosis. Eur J Clin Pharmacol. 28:1985;475-477.
42. Podesta A, Lopez P, Terg R, Villamil F, Flores D, Mastai R, Udaondo CB, Companc JP. Treatment of pruritus of primary biliary cirrhosis with rifampin. Dig Dis Sci. 36:1991;216-220.
43. Bachs L, Parés A, Elena M, Piera C, Rodés. Effect of longterm rifampicin administration in primary biliary cirrhosis. Gastroenterology. 102:1992;2077-2080.